sibrotuzumab

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
  • 2017
EP O953639 A1 11, 1999 EP 1258255 A1 11, 2002 WO 99.57151 A2 11/1999 WO O1687.08 A2 9, 2001 WO 02083171 10, 2002 WO 2005060999 A2… (More)
  • figure 5
Is this relevant?
2007
2007
Sarcomatous transformation of a granulosa cell tumor (GCT) is a rare event. We describe the development of a rapidly progressive… (More)
Is this relevant?
2005
2005
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… (More)
Is this relevant?
2004
2004
Population pharmacokinetics of sibrotuzumab, a humanized monoclonal antibody directed against fibroblast activation protein, were… (More)
Is this relevant?
2004
2004
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE The purpose of this research was to determine the safety, immunogenicity, pharmacokinetics, biodistribution, and tumor… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND A novel immunological approach to colon cancer therapy is the antibody targeting of the fibroblast activation protein… (More)
Is this relevant?
2003
2003
Purpose: The purpose of this research was to determine the safety, immunogenicity, pharmacokinetics, biodistribution, and tumor… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2003
2003
The conventional concept of tumor-host interactions is rooted in the realm of parasitology. A tumor invades an unsuspecting host… (More)
Is this relevant?